Vicente E Torres Selected Research

mozavaptan

7/2008	Role of vasopressin antagonists.
5/2008	Vasopressin antagonists in polycystic kidney disease.
4/2005	Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vicente E Torres Research Topics

Disease

130	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 08/2000
52	Cysts 03/2022 - 08/2000
44	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2022 - 11/2003
26	Disease Progression 01/2022 - 08/2000
20	Polycystic liver disease 01/2020 - 01/2003
16	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 11/2019 - 03/2002
13	Hypertension (High Blood Pressure) 04/2021 - 08/2003
12	Chronic Renal Insufficiency 07/2021 - 05/2008
12	Chronic Kidney Failure (Chronic Renal Failure) 04/2021 - 05/2002
10	Fibrosis (Cirrhosis) 01/2022 - 11/2003
10	Liver Diseases (Liver Disease) 01/2020 - 11/2004
6	Inflammation (Inflammations) 01/2022 - 02/2013
5	Pain (Aches) 01/2020 - 06/2010
5	Hypotension (Low Blood Pressure) 05/2018 - 03/2012
4	Ciliopathies 01/2022 - 09/2009
4	Heart Failure 07/2021 - 05/2013
3	Body Weight (Weight, Body) 04/2021 - 11/2003
3	Kidney Diseases (Kidney Disease) 10/2020 - 02/2017
3	Cystic Kidney Diseases (Cystic Kidney Disease) 03/2020 - 01/2008
3	Renal Insufficiency (Renal Failure) 01/2020 - 12/2003
3	Hepatomegaly 11/2014 - 07/2009
2	Nephrocalcinosis 03/2022 - 07/2021
2	Hypercalciuria 03/2022 - 07/2021
2	Chemical and Drug Induced Liver Injury 12/2020 - 11/2015
2	Hyperglycemia 01/2020 - 08/2012
2	Hypertrophy 01/2019 - 01/2015
2	Kidney Calculi (Kidney Stone) 02/2017 - 01/2010
2	Albuminuria 11/2016 - 10/2011
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2016 - 01/2001

Drug/Important Bio-Agent (IBA)

37	Tolvaptan FDA Link 08/2021 - 04/2005
27	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2001
21	CreatinineIBA 06/2021 - 08/2000
19	TEMPOIBA 08/2021 - 05/2011
18	Vasopressins (Vasopressin)IBA 10/2021 - 01/2008
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2000
17	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2021 - 01/2004
14	1-dodecylpyridoxal (PLD)IBA 01/2020 - 07/2009
12	CalciumIBA 10/2021 - 01/2006
9	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 03/2007
8	Pharmaceutical PreparationsIBA 11/2021 - 08/2013
7	Iothalamic Acid (Iotalamic Acid)FDA Link 12/2018 - 08/2000
7	Arginine Vasopressin (Argipressin)IBA 01/2017 - 01/2008
6	SodiumIBA 04/2021 - 01/2007
6	AlbuminsIBA 11/2016 - 09/2003
6	Octreotide (Sandostatin)FDA LinkGeneric 04/2016 - 03/2007
6	Antidiuretic Hormone Receptor AntagonistsIBA 04/2015 - 11/2005
5	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 11/2004
4	EnzymesIBA 07/2021 - 06/2004
4	Cyclic AMP (AMP, Cyclic)IBA 01/2020 - 04/2004
4	TRPP Cation ChannelsIBA 11/2019 - 09/2003
4	AngiotensinsIBA 05/2018 - 03/2012
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015 - 10/2011
4	Adenosine Monophosphate (AMP)IBA 01/2015 - 06/2009
3	Epidermal Growth Factor (EGF)IBA 06/2021 - 11/2003
3	BilirubinIBA 12/2020 - 01/2003
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 03/2007
3	pasireotideIBA 01/2020 - 07/2013
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020 - 01/2016
3	polycystic kidney disease 1 proteinIBA 11/2019 - 02/2009
3	Sirolimus (Rapamycin)FDA Link 12/2018 - 03/2008
3	Transaminases (Aminotransferases)IBA 11/2017 - 11/2015
3	Angiotensin Receptor AntagonistsIBA 01/2015 - 10/2011
3	mozavaptanIBA 07/2008 - 04/2005
2	Vitamin D FDA LinkGeneric 03/2022 - 07/2021
2	Vitamin D3 24-HydroxylaseIBA 03/2022 - 07/2021
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 11/2019
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2022 - 01/2020
2	lixivaptanIBA 10/2021 - 01/2019
2	Calcium-Sensing ReceptorsIBA 10/2021 - 02/2009
2	N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamineIBA 10/2021 - 02/2009
2	Pioglitazone (Actos)FDA Link 07/2021 - 01/2010
2	Antihypertensive Agents (Antihypertensives)IBA 04/2021 - 04/2011
2	Fibroblast Growth Factor-23IBA 04/2021 - 12/2019
2	SaltsIBA 11/2020 - 10/2020
2	Dietary SodiumIBA 11/2020 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020 - 01/2020
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2020 - 01/2003
2	Cyclic NucleotidesIBA 01/2020 - 01/2010
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2020 - 11/2004
2	polycystic kidney disease 2 proteinIBA 11/2019 - 02/2009
2	ReninIBA 05/2018 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 01/2016
2	adenylyl cyclase 6IBA 01/2017 - 01/2015
2	lanreotide (Somatuline)FDA Link 04/2016 - 03/2014
2	Alkaline PhosphataseIBA 04/2016 - 01/2003
2	4-nitrophenyl-alpha-glucosidaseIBA 01/2016 - 06/2004
2	diethylstilbestrol monophosphate (PDES)IBA 01/2016 - 01/2010
2	RNA (Ribonucleic Acid)IBA 01/2016 - 10/2014
2	Telmisartan (Micardis)FDA Link 12/2014 - 12/2014
2	Lisinopril (Prinivil)FDA LinkGeneric 12/2014 - 12/2014
2	Indicators and Reagents (Reagents)IBA 01/2014 - 07/2013
2	ElectrolytesIBA 12/2012 - 09/2003

Therapy/Procedure

26	Therapeutics 01/2021 - 12/2003
3	Kidney Transplantation 01/2021 - 08/2012
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 01/2015
2	Nephrectomy 01/2021 - 11/2015
2	Treatment Delay 01/2018 - 01/2017
2	Liver Transplantation 01/2016 - 07/2009
2	Hepatectomy 01/2016 - 07/2009
2	Transplantation 01/2016 - 08/2012